Expanding Into Clinical Trials

Site Network

How Regional Sites in a Global Site Network Combine Local Insight with Global Scale

Darin Brimhall, D.O., FACP

PPD clinical research business of Thermo Fisher Scientific

Clinical Diversity

Driving Diversity and Accessibility in Clinical Trials Starts at the Community Level

Melissa Choi, M.D.

Trialmed

AOCs

Antibody–Oligonucleotide Conjugates Clinical Manufacturing — A New Paradigm Shift of Bio-Conjugates for Therapeutics

Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.

GBI Biomanufacturing

Pathfinder

Surrogate Endpoints vs. Clinical Endpoints: Which Evidence Strategy Is Better for Drug Development?

Pharma's Almanac

Supply Chain

Supply Chain Resilience Is Not an Insurance Cost, but Value Protection

Anurag Bhagania

OneSource Specialty Pharma

Self-Injection

The Quiet Revolution in How We Take Our Medicine

Ravi Kumar

OneSource Specialty Pharma

Innovation Partner

CDMOs as Innovation Partners in R&D

Prateek Gupta, Ph.D.

OneSource Specialty Pharma

Asia Manufacturing

The New Manufacturing Map of Asia

Pharma's Almanac

Asia Manufacturing

APAC Expands Specialized Manufacturing Capabilities Across High-Value Modalities

Pharma's Almanac

Geopolitics

How are geopolitical factors influencing sourcing and manufacturing decisions for 2026 and beyond?

Pharma's Almanac

ADC Formulation

Controlling Complexity in ADC Formulation Development

Eunbi Iris Cho, Ph.D.

Samsung Biologics